Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension

• Main Authors: Enrico Gugliandolo (Author), Francesco Macrì (Author), Roberta Fusco (Author), Rosalba Siracusa (Author), Marika Cordaro (Author), Ramona D'amico (Author), Alessio Filippo Peritore (Author), Daniela Impellizzeri (Author), Tiziana Genovese (Author), Salvatore Cuzzocrea (Author), Rosanna Di Paola (Author), Rosalia Crupi (Author)
• Format: Book
• Published: Elsevier, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease characterized by an increase in blood pressure in the lungs' arteries. It can occur in a variety of species, including humans, dogs, cats, and horses. To date, PAH has a high mortality rate in both veterinary and human medi...